Right heart dysfunction in heart failure with preserved ejection fraction
about
Pulmonary hypertension in patients with heart failure and preserved ejection fraction: differential diagnosis and managementHow to diagnose heart failure with preserved ejection fraction: the value of invasive stress testingUnderstanding heart failure with preserved ejection fraction: where are we today?Left ventricular heart failure and pulmonary hypertensionThe year in cardiology 2015: imagingOestradiol metabolism and androgen receptor genotypes are associated with right ventricular functionAdvances in the pathophysiology and treatment of heart failure with preserved ejection fractionThe Critical Role of Pulmonary Arterial Compliance in Pulmonary Hypertension.The role of phosphodiesterase inhibitors in the management of pulmonary vascular diseasesDiagnosing and treating the failing right heart.Quantification of atrial dynamics using cardiovascular magnetic resonance: inter-study reproducibility.Outcome in Heart Failure with Preserved Ejection Fraction: The Role of Myocardial Structure and Right Ventricular PerformancePulmonary artery to aorta ratio for the detection of pulmonary hypertension: cardiovascular magnetic resonance and invasive hemodynamics in heart failure with preserved ejection fractionDual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection FractionAssociation of chronic kidney disease with abnormal cardiac mechanics and adverse outcomes in patients with heart failure and preserved ejection fraction.Impaired Right Ventricular-Pulmonary Arterial Coupling and Effect of Sildenafil in Heart Failure With Preserved Ejection Fraction: An Ancillary Analysis From the Phosphodiesterase-5 Inhibition to Improve Clinical Status And Exercise Capacity in DiasPhenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.Prognostic Importance of Changes in Cardiac Structure and Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone.Pulmonary pulse wave transit time is associated with right ventricular-pulmonary artery coupling in pulmonary arterial hypertension.Association of Systemic Arterial Properties With Right Ventricular Morphology: The Multi-Ethnic Study of Atherosclerosis (MESA)-Right Ventricle Study.Heart failure with preserved ejection fraction in the elderly: scope of the problem.Heart failure with preserved ejection fraction: current understandings and challenges.Pulmonary hypertension 2015: current definitions, terminology, and novel treatment options.INDIE-HFpEF (Inorganic Nitrite Delivery to Improve Exercise Capacity in Heart Failure With Preserved Ejection Fraction): Rationale and Design.Heart failure with preserved ejection fraction: uncertainties and dilemmas.Pulmonary Hypertension in Heart Failure. Epidemiology, Right Ventricular Function, and Survival.Epidemiology of Right Ventricular Dysfunction in Heart Failure with Preserved Ejection Fraction.Beyond ejection fraction: an integrative approach for assessment of cardiac structure and function in heart failure.Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation.Evolving Concepts of Pulmonary Hypertension Secondary to Left Heart Disease.Management of Heart Failure with Preserved Ejection Fraction: Current Challenges and Future Directions.Towards Precision in HF Pharmacotherapy.Pedal Edema as an Indicator of Early Heart Failure in the Community: Prevalence and Associations With Cardiac Structure/Function and Natriuretic Peptides (MESA [Multiethnic Study of Atherosclerosis]).Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta-analysis.Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction.Prognostic incremental role of right ventricular function in acute decompensation of advanced chronic heart failure.Diastolic Dysfunction Is a Contributing Factor to Exercise Intolerance in COPD.Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction.Lung congestion in chronic heart failure: haemodynamic, clinical, and prognostic implications.The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics.
P2860
Q26750994-FC1991AD-04F5-4AC5-A36D-E68BC0406C2CQ26766355-C51557F6-6241-4CE6-B4D3-391DD01611FFQ26766590-2C81A032-F0E2-4AC5-BE77-CA3FD1CF4131Q26778341-8B6AD8A7-CD98-4D55-8D46-3795409F11CBQ28072439-D318D85B-5638-42A9-A613-C0D575D76279Q30277940-3BA9DC8E-AC81-49F1-9759-2905AA8F10B1Q33565707-141A660F-7A1A-411B-AA59-D4CB38477D9AQ33772330-E7FCBEFF-55E6-4E17-A7A5-AF575D8D9DF8Q35156618-7D2F8AD5-EEF7-40A6-A4B5-750C1040BA66Q35599768-9FB15742-00AC-48F3-8B14-60EBE7D6D22BQ35616536-D2D52FDF-5793-40EB-A952-2D13F69B39ECQ35725839-44FF18EC-2374-40A1-858B-0EE2453E1630Q36006309-F955A35A-C7A0-412C-A67A-E7A7B9AC341BQ36181771-4B477E1E-D896-4E7C-B1CD-D901AAE79FEEQ36463883-B10527BA-02B8-4514-985A-70E04C62A8B8Q36796620-116BF3EF-2E6F-482D-8A63-4C3F35CB8AAFQ37058596-30F6B92D-3047-494F-A8AC-C022DE24472CQ37075193-2A0BB625-9FE8-41BB-889F-8ACA767E807AQ37555462-0D60AC81-C838-4855-AB03-684248DA21ACQ37556260-3B79E5FE-DC7F-479F-A8AF-1DCED142C7F8Q37633991-ECA396C7-ACAF-445C-A405-FF2265C15D76Q38217344-3A8F9E3A-C301-46D7-B5DD-2B1B666A890EQ38283873-D29CB456-2226-4ED5-8D9F-58F5D03C21FCQ38377133-5E9FEA30-5C60-467A-A1EA-DC4A376071D5Q38529003-50184594-CBBD-4F98-8D04-63AD390BD6E0Q38548379-0CFE9E22-318B-458A-BE24-4AE90D5C3026Q38580530-22AC1899-366F-4CAD-A878-CF9E9E4494B1Q38594949-F2C9E199-236E-436E-9B38-D3BBA98B9832Q38727741-BF5B5C6B-7C39-4A51-AE4B-96F4E6C8EF68Q38737284-9B8C040E-693A-4177-A27F-55F36BF54056Q38743215-6235DAA4-0FBA-48F8-8E38-7A3679433B8AQ38758440-4356F725-BDEA-4A5E-8238-F59D02761242Q38786427-B23143DB-9538-4089-89E9-D8056AF0570BQ38959952-7D55A571-690B-427E-BD47-7BA28025A84EQ39647469-3CBBEBE2-059B-4D79-A3DE-9634089975D8Q39909267-B29DA50E-FBA8-49B3-96B5-A01851801551Q40195968-3D16522C-8B08-4897-A1DA-F32DEBAFBDDFQ40256097-F5A03A8F-9802-4DCE-AC80-1CE207F79DB5Q40431837-B609BA79-DE24-41CF-BB89-DA121A6A3932Q40451398-906CE092-DD04-4B06-AD3B-43E5E4AA090A
P2860
Right heart dysfunction in heart failure with preserved ejection fraction
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Right heart dysfunction in heart failure with preserved ejection fraction
@ast
Right heart dysfunction in heart failure with preserved ejection fraction
@en
type
label
Right heart dysfunction in heart failure with preserved ejection fraction
@ast
Right heart dysfunction in heart failure with preserved ejection fraction
@en
prefLabel
Right heart dysfunction in heart failure with preserved ejection fraction
@ast
Right heart dysfunction in heart failure with preserved ejection fraction
@en
P2093
P2860
P356
P1476
Right heart dysfunction in heart failure with preserved ejection fraction
@en
P2093
Margaret M Redfield
Seok-Jae Hwang
P2860
P304
P356
10.1093/EURHEARTJ/EHU193
P577
2014-05-29T00:00:00Z